China-based startup Cornerstone Robotics, a leading global innovator in surgical robotics, has announced the closing of an oversubscribed new financing round of approximately $200 million. This financing round attracts investment from a global strategic investor, some global institutional or sovereign wealth funds, and existing shareholders. The proceeds from this round will primarily be used to accelerate commercialisation and drive continued technological innovation by Cornerstone Robotics.
With its industry-leading technologies and strong growth potential in the field of surgical robotics, Cornerstone Robotics has attracted a global strategic investor in this financing round. The Company also welcomed some global institutional or sovereign wealth funds, whose participation will further support Cornerstone Robotics’ market access and strategic partnerships globally. Existing shareholders have also increased their investment, reaffirming their strong confidence in the company’s technological capabilities and future roadmap, commercialisation progress, and long-term growth potential. Together, this powerful investor lineup strengthens Cornerstone Robotics’ global foundation and accelerates its mission to make safe, efficient, and accessible surgical robotic technologies available to healthcare providers worldwide.
The company’s flagship product, the Sentire® Endoscopic Surgical System, has received approval from China’s National Medical Products Administration (NMPA) and has entered clinical use in leading hospitals across the Chinese mainland, Hong Kong, and Europe.
